Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach

[1] van Heijl M.(2008)Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus. (CROSS) BMC Surg 8 21-530

[2] van Lanschot J.J.(2001)Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies Ann Surg 234 520-664

[3] Koppert L.B.(2001)Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus Int J Radiat Oncol 3 657-261

[4] Hagen J.A.(2003)Niveles de calidad exigibles en cuanto a tecnología y procedimientos en la cirugía del cáncer de esófago Cir Esp 74 256-1220

[5] DeMeester S.R.(1998)POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity Br J Surg 85 1217-1459

[6] Peters J.H.(1998)Classification of adenocarcinoma of the esophagogastric junction Br J Surg 85 1457-1530

[7] Hennequin C.(2003)Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Cancer 98 1521-435

[8] Gayet B.(1999)Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans Ann Thorac Surg 68 1133-705

[9] Sauvanet A.(2010)Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing J Am Coll Surg 210 428-442

[10] Pera M.(2009)Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study Clin Radiol 64 699-2192

[1] van Heijl M.(2008)Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus. (CROSS) BMC Surg 8 21-530

[2] van Lanschot J.J.(2001)Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies Ann Surg 234 520-664

[3] Koppert L.B.(2001)Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus Int J Radiat Oncol 3 657-261

[4] Hagen J.A.(2003)Niveles de calidad exigibles en cuanto a tecnología y procedimientos en la cirugía del cáncer de esófago Cir Esp 74 256-1220

[5] DeMeester S.R.(1998)POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity Br J Surg 85 1217-1459

[6] Peters J.H.(1998)Classification of adenocarcinoma of the esophagogastric junction Br J Surg 85 1457-1530

[7] Hennequin C.(2003)Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Cancer 98 1521-435

[8] Gayet B.(1999)Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans Ann Thorac Surg 68 1133-705

[9] Sauvanet A.(2010)Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing J Am Coll Surg 210 428-442

[10] Pera M.(2009)Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study Clin Radiol 64 699-2192